Literature DB >> 20046003

Polymyxin B-immobilized fiber column hemoperfusion treatment for drug-induced severe respiratory failure: report of three cases.

Toshiki Yokoyama1, Kenji Tsushima, Hiroshi Yamamoto, Michiko Ito, Toshihiko Agatsuma, Tomonobu Kozumi, Keishi Kubo.   

Abstract

The effects of direct hemoperfusion with polymyxin B-immobilized fiber (PMX-DHP) treatment for acute exacerbation of interstitial pneumonia have been reported. Here, we report 3 severe cases of drug-induced interstitial lung disease (DI-ILD) that were treated with PMX-DHP. Two DI-ILD cases were caused by methotrexate, and the third case was caused by the herbal medicine sanmotsu-ogon-to. The arterial oxygen tension/inspiratory oxygen fraction ratio improved during PMX-DHP treatment in all 3 patients. Finally, 2 patients survived and 1 died. The study findings indicate that PMX-DHP treatment is a viable option for the management of acute respiratory failure in patients with DI-ILD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20046003     DOI: 10.2169/internalmedicine.49.2213

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Severe acute respiratory failure due to Sai-rei-to-induced lung injury successfully treated by multi-modal therapy including immunosuppressive therapy, plasma exchange, and intravenous immunoglobulin: A case report.

Authors:  Midori Yamada; Kei Nakashima; Hiroyuki Ito; Masahiro Aoshima
Journal:  Respir Med Case Rep       Date:  2019-10-16

Review 2.  Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridge.

Authors:  Elisabeth Esteban; Ricard Ferrer; Laia Alsina; Antonio Artigas
Journal:  Mediators Inflamm       Date:  2013-10-22       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.